1-241568552-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003679.5(KMO):c.862G>A(p.Val288Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003679.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KMO | NM_003679.5 | c.862G>A | p.Val288Ile | missense_variant | 10/15 | ENST00000366559.9 | |
KMO | NM_001410944.1 | c.862G>A | p.Val288Ile | missense_variant | 10/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KMO | ENST00000366559.9 | c.862G>A | p.Val288Ile | missense_variant | 10/15 | 1 | NM_003679.5 | P2 | |
KMO | ENST00000366558.7 | c.862G>A | p.Val288Ile | missense_variant | 10/15 | 1 | A2 | ||
KMO | ENST00000366557.8 | c.862G>A | p.Val288Ile | missense_variant | 10/14 | 5 | |||
KMO | ENST00000431245.2 | n.451G>A | non_coding_transcript_exon_variant | 4/5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251110Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135710
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461488Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727042
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2023 | The c.862G>A (p.V288I) alteration is located in exon 10 (coding exon 10) of the KMO gene. This alteration results from a G to A substitution at nucleotide position 862, causing the valine (V) at amino acid position 288 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at